Former senior Biogen and Roche executive brings deep experience across Alzheimer’s clinical development, launch readiness, commercialization and global medical strategy

Appointment strengthens commercial and development leadership as PMN310 advances toward 12-month topline data expected in Q1 2027

Globenewswire